Skip to content

Research on the intervention effect of personalized chronic disease exercise prescription based on ICF on diabetic populations

Research on the intervention effect of personalized chronic disease exercise prescription based on ICF on diabetic populations

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122325
Enrollment
Unknown
Registered
2026-04-12
Start date
2025-11-11
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:Receive personalized exercise prescription interventions for chronic diseases, including health education, comprehensive medical assessments and services, intelligent wearable devic
Control group:Maintain routine treatment, including medication, health guidance and telephone follow-up.

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Permanent residents of the province (residence time > 6 months); 2. Age 18-75 years old; 3. BMI 18.5-35 kg/m^2; 4. Meet the diagnostic criteria of type 2 diabetes mellitus (fasting blood glucose >=7.0 mmol/L, or HbA1c >=6.5%); 5. The course of the disease is >=6 months, and the condition is stable (the dose of hypoglycemic drugs or insulin has not been adjusted in the past 3 months); 6. Have certain exercise ability and be able to safely participate in moderate-intensity exercise; 7. Written informed consent for the purpose of this study; 8. Commitment to complete >=80% of the intervention sessions and follow-up assessments.

Exclusion criteria

Exclusion criteria: 1. Severe diabetic complications, such as diabetic nephropathy stage 4, proliferative retinopathy, diabetic foot Wagner grade >= grade 2, or lower extremity arterial stenosis (ABI 16.7 mmol/L or random blood glucose <3.9 mmol/L (high risk of hypoglycemia), acute infection (such as pneumonia, urinary tract infection) or recovery period of diabetic ketoacidosis, etc.; 5. Presence of mental illness or cognitive impairment (MMSE < 24 points); 6. Patients whose doctors make decisions based on objective judgment that contraindicate exercise intervention.

Design outcomes

Primary

MeasureTime frame
Dynamic glucose monitoring CGM;

Secondary

MeasureTime frame
Body composition analysis;Blood pressure;Cardiorespiratory function;International Classification of Functioning, Disability and Health (ICF);Self-Rating Depression Scale (SDS);Self-Rating Anxiety Scale (SAS);International function;Cost of using hypoglycaemic drugs;

Countries

China

Contacts

Public ContactLi Yongqiang

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

liyongqiang_1980@163.com+86 133 2782 9260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026